The BBCR team designs Proof of Concept (PoC) Trials and Proof of Mechanism (PoM) studies with the drug clinical plan and regulatory strategy in mind. Proof of Mechanism (PoM) Usually in Healthy Volunteers, Phase 1 study Essential for the selection of appropriate dose for PoC, disease model and biomarkers Investigate drug concentration at the target […]
Tagged: Early product development
BBCR uses innovative approaches to de-risk your product development. For our clients interested in Proof of Concept and Proof of Mechanism – PoC and PoM – Our team has the expertise to ensure successful product development at any stage of development.
December 12th, 2023 | Early product developmentThe BBCR team is highly experienced in crafting innovative approaches to de-risk your product development during the early clinical development stage.
December 20th, 2021 | Early product developmentDepending on your project goals, our consultants’ work with you to design cost-effective early clinical studies that holds potential for reducing Phase III failures. Our team of consultants can assist in the areas of: POM & POC Translational Research Clinical Plan & Study Design Phase 1 & Phase 2 Protocol Development Medical Monitors Study Management […]
Potential of Gene Therapies in Rare Disorders
November 12th, 2019 | Early product developmentBBCR Consulting, for the first time this year, decided to attend on October 15th – 17th in London- UK, the European edition of the Gene Therapies in Rare Disorders conference. In our opinion, the event, as promised, proven to be: ”…uniquely focused conference that will bring the leaders in the field together to discuss the […]